Assenagon Asset Management
VRTX icon

Assenagon Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$108M Buy
242,754
+34,614
+17% +$15.4M 0.16% 118
2025
Q1
$101M Sell
208,140
-631,532
-75% -$306M 0.17% 96
2024
Q4
$338M Buy
839,672
+528,029
+169% +$213M 0.55% 23
2024
Q3
$145M Buy
311,643
+215,448
+224% +$100M 0.27% 51
2024
Q2
$45.1M Sell
96,195
-226,893
-70% -$106M 0.1% 135
2024
Q1
$135M Buy
323,088
+26,935
+9% +$11.3M 0.32% 46
2023
Q4
$121M Buy
296,153
+93,922
+46% +$38.2M 0.32% 49
2023
Q3
$70.3M Sell
202,231
-182,487
-47% -$63.5M 0.22% 70
2023
Q2
$135M Sell
384,718
-234,078
-38% -$82.4M 0.47% 29
2023
Q1
$195M Sell
618,796
-120,191
-16% -$37.9M 0.69% 21
2022
Q4
$213M Buy
738,987
+76,752
+12% +$22.2M 0.77% 18
2022
Q3
$192M Buy
662,235
+146,237
+28% +$42.3M 0.74% 19
2022
Q2
$145M Sell
515,998
-292,556
-36% -$82.4M 0.54% 24
2022
Q1
$211M Buy
808,554
+486,323
+151% +$127M 0.59% 23
2021
Q4
$70.8M Buy
322,231
+252,752
+364% +$55.5M 0.21% 66
2021
Q3
$12.6M Sell
69,479
-166,649
-71% -$30.2M 0.04% 229
2021
Q2
$47.6M Sell
236,128
-37,631
-14% -$7.59M 0.16% 91
2021
Q1
$58.8M Sell
273,759
-324,687
-54% -$69.8M 0.24% 62
2020
Q4
$141M Buy
598,446
+474,130
+381% +$112M 0.62% 23
2020
Q3
$33.8M Sell
124,316
-1,314
-1% -$358K 0.19% 67
2020
Q2
$36.5M Sell
125,630
-641,941
-84% -$186M 0.23% 62
2020
Q1
$183M Buy
767,571
+498,163
+185% +$119M 1.46% 14
2019
Q4
$59M Buy
269,408
+240,816
+842% +$52.7M 0.37% 38
2019
Q3
$4.84M Buy
28,592
+19,333
+209% +$3.28M 0.03% 208
2019
Q2
$1.7M Sell
9,259
-59,305
-86% -$10.9M 0.01% 535
2019
Q1
$12.6M Sell
68,564
-315,198
-82% -$58M 0.12% 130
2018
Q4
$63.6M Buy
383,762
+192,494
+101% +$31.9M 0.72% 19
2018
Q3
$36.9M Sell
191,268
-173,500
-48% -$33.4M 0.36% 38
2018
Q2
$62M Buy
364,768
+212,481
+140% +$36.1M 0.72% 19
2018
Q1
$24.8M Sell
152,287
-6,287
-4% -$1.02M 0.32% 51
2017
Q4
$23.8M Sell
158,574
-734,806
-82% -$110M 0.24% 52
2017
Q3
$136M Buy
893,380
+883,998
+9,422% +$134M 1.26% 7
2017
Q2
$1.21M Buy
+9,382
New +$1.21M 0.03% 80